Mangiferin Ameliorates HFD-Induced NAFLD through Regulation of the AMPK and NLRP3 Inflammasome Signal Pathways
Nonalcoholic fatty liver disease (NAFLD) is closely related to glycolipid metabolism and liver inflammation. And there is no effective drug approved for its clinical therapy. In this study, we focused on mangiferin (Man) and explored its effects and mechanisms on NAFLD treatment based on the regulat...
Saved in:
Main Authors: | Zhang Yong, Wang Ruiqi, Yao Hongji, Ma Ning, Jiang Chenzuo, Zhou Yu, Xia Zhixuan, Liu Qiang, Liu Qibing, Lu Weiying, Zhang Xiaopo |
---|---|
Format: | article |
Language: | EN |
Published: |
Hindawi Limited
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/48cf01e5bbfd4547858d98a577ab9a0e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation
by: Li N, et al.
Published: (2021) -
Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
by: Congfei Xu, et al.
Published: (2018) -
Anti-NAFLD Effect of Djulis Hull and Its Major Compound, Rutin, in Mice with High-Fat Diet (HFD)-Induced Obesity
by: Yu-Tang Tung, et al.
Published: (2021) -
Study of the interaction between self-assembling peptide and mangiferin and in vitro release of mangiferin from in situ hydrogel
by: Meng C, et al.
Published: (2019) -
Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018)